Affordable Access

Access to the full text

A model for determining cardiac mitochondrial substrate utilisation using stable 13C-labelled metabolites

Authors
  • Lindsay, Ross T.1, 1
  • Demetriou, Demetris1
  • Manetta-Jones, Dominic1
  • West, James A.1
  • Murray, Andrew J.1
  • Griffin, Julian L.1
  • 1 University of Cambridge, Cambridge, UK , Cambridge (United Kingdom)
Type
Published Article
Journal
Metabolomics
Publisher
Springer US
Publication Date
Nov 26, 2019
Volume
15
Issue
12
Identifiers
DOI: 10.1007/s11306-019-1618-y
Source
Springer Nature
Keywords
License
Green

Abstract

IntroductionRelative oxidation of different metabolic substrates in the heart varies both physiologically and pathologically, in order to meet metabolic demands under different circumstances. 13C labelled substrates have become a key tool for studying substrate use—yet an accurate model is required to analyse the complex data produced as these substrates become incorporated into the Krebs cycle.ObjectivesWe aimed to generate a network model for the quantitative analysis of Krebs cycle intermediate isotopologue distributions measured by mass spectrometry, to determine the 13C labelled proportion of acetyl-CoA entering the Krebs cycle.MethodsA model was generated, and validated ex vivo using isotopic distributions measured from isolated hearts perfused with buffer containing 11 mM glucose in total, with varying fractions of universally labelled with 13C. The model was then employed to determine the relative oxidation of glucose and triacylglycerol by hearts perfused with 11 mM glucose and 0.4 mM equivalent Intralipid (a triacylglycerol mixture).ResultsThe contribution of glucose to Krebs cycle oxidation was measured to be 79.1 ± 0.9%, independent of the fraction of buffer glucose which was U-13C labelled, or of which Krebs cycle intermediate was assessed. In the presence of Intralipid, glucose and triglyceride were determined to contribute 58 ± 3.6% and 35.6 ± 0.8% of acetyl-CoA entering the Krebs cycle, respectively.ConclusionThese results demonstrate the accuracy of a functional model of Krebs cycle metabolism, which can allow quantitative determination of the effects of therapeutics and pathology on cardiac substrate metabolism.

Report this publication

Statistics

Seen <100 times